News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AMAG Pharmaceuticals, Inc. (AMAG) Finds Safety Issues With Kidney Drug, Feraheme, Slashes Jobs by 24%


10/29/2010 6:58:18 AM

Oct 28 (Reuters) - AMAG Pharmaceuticals (AMAG.O) found potential safety issues with its key kidney drug Feraheme, which reported declining sales, and said it will cut about a fourth of its workforce, sending the stock crashing 25 percent in extended trade.

Read at Reuters
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES